Latest Regulatory News

Rio Tinto has officially ended merger discussions with Glencore, citing an inability to reach a deal that benefits shareholders. The decision underscores Rio Tinto’s disciplined approach to long-term value creation.

BlackRock Investment Management (Australia) Limited has announced confirmed cash distributions for four Australian iShares ETFs, detailing payment schedules and reinvestment options for investors.

New Age Exploration Limited has issued a prospectus to facilitate secondary trading of new options issued under a recent $3.75 million placement, offering 1,000 new options at $0.01 each. The move aims to remove trading restrictions and improve liquidity for option holders.

WRKR Ltd has completed its strategic acquisition of PaidRight Holdings, issuing over 90 million shares to expand its compliance platform into payroll compliance. This move marks a significant step beyond superannuation, aiming to create a comprehensive compliance solution.

Manuka Resources’ subsidiary Trans-Tasman Resources has received a draft decision proposing to decline consent for its Taranaki VTM iron sands project, challenging the company’s plans to develop a critical minerals supply in New Zealand.

US1 Critical Minerals Limited has launched a substantial options offer to existing shareholders and institutional investors, aiming to raise up to $5.9 million upon exercise, while navigating ongoing litigation and capital challenges.

Apiam Animal Health Limited has announced a special fully franked dividend of AUD 0.10 per share, with payment scheduled for mid-February 2026. Notably, the company has suspended its dividend reinvestment plan for this payout.

Apiam Animal Health has announced a fully franked special dividend of 10 cents per share, payable before the completion of its proposed acquisition by Adamantem Capital entities. The dividend is conditional on the scheme’s effectiveness and offers shareholders potential tax benefits through franking credits.

Lotus Resources has launched a A$81 million equity raising to support the ramp-up of its Kayelekera uranium mine to steady state production targeted in Q2 2026, while advancing development of its Letlhakane project.

Epsilon Healthcare’s subsidiary, Epsilon Pharma, has signed a three-year manufacturing agreement with New Zealand’s Puro to supply medicinal cannabis products to the UK and Europe, marking a significant step in its international expansion.

Red Mountain Mining has acquired the Thompson Falls Antimony Project on the Montana-Idaho border, adjacent to the only operating antimony smelter in the US. Early assays reveal exceptional grades, positioning the company to capitalise on critical mineral supply chain demands.

Greenwing Resources updates its strategy for the Que River Project, combining a renewed mining push with an innovative plan to develop digital infrastructure on site.